Study details
Enrolling now
Comprehensive Esophageal Diagnostics Trial
Emory University
NCT IDNCT04641702ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
80
Study length
about 5.8 years
Ages
18+
Locations
2 sites in GA
What this study is about
This trial is testing a treatment and procedure to understand esophageal muscle fibrosis in people with achalasia. The goal is to improve the understanding of achalasia so that intervention can be done earlier.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Atropine challenge
- 2.Undergo Esophageal muscle biopsy
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
ALIMENTARY TRACT AND METABOLISM
Procedures
biopsy